N-doped TiO₂ with stable surface Ti³⁺ for visible light photocatalytic hydrogen production by Jieming Chen (386865)

“…After modification, the band gap of the catalyst decreased from 3.2 eV to 2.83 eV. This study elucidates the synergistic effects among Ti³⁺ species, nitrogen dopants, and oxygen vacancies in TiO₂-based photocatalysts, demonstrating their crucial roles in enhancing visible-light-driven hydrogen evolution.…”

Background compensation by coherent feedback in the scheme of Fig 13. by Melissa Nygård (15374507)

<b>IMPACT OF MULTIVITAMINS AND PROCESSED MEAT ON AGING: A MACHINE LEARNING APPROACH</b> by Mohcene M. (20142864)

Supplementary Material for: Spurious Hyperchloremia in the Presence of Elevated Plasma Salicylate: A Cohort Study by Kashani K.B. (3418163)

Influence of Solubilizing Group Removal Rate on the Morphology and Crystallinity of a Diketopyrrolopyrrole-Based Compound by Shabi Thankaraj Salammal (1864396)

“…The X-ray and atomic force microscopic investigations of “3,6-di­(2,2′-bithio­phen-5-yl)­pyrrolo­[3,4-<i>c</i>]­pyrrole-1,4-(2<i>H</i>,5<i>H</i>)-dione” (DPP-4T) synthesized from its precursor (di-<i>tert</i>-butyl-3,6-di­(2,2′-bithio­phen-5-yl)-1,4-dioxo­pyrrolo­[3,4-<i>c</i>]­pyrrole-2,5-(1<i>H</i>,4<i>H</i>)-dicarboxylate) through thermal conversion reveals that the solubilizing group removal rate plays a crucial role on the ultimate grain size and crystallinity of the final compound (DPP-4T). …”

Influence of Solubilizing Group Removal Rate on the Morphology and Crystallinity of a Diketopyrrolopyrrole-Based Compound by Shabi Thankaraj Salammal (1864396)

“…The X-ray and atomic force microscopic investigations of “3,6-di­(2,2′-bithio­phen-5-yl)­pyrrolo­[3,4-<i>c</i>]­pyrrole-1,4-(2<i>H</i>,5<i>H</i>)-dione” (DPP-4T) synthesized from its precursor (di-<i>tert</i>-butyl-3,6-di­(2,2′-bithio­phen-5-yl)-1,4-dioxo­pyrrolo­[3,4-<i>c</i>]­pyrrole-2,5-(1<i>H</i>,4<i>H</i>)-dicarboxylate) through thermal conversion reveals that the solubilizing group removal rate plays a crucial role on the ultimate grain size and crystallinity of the final compound (DPP-4T). …”

Nutritional profile of patients in a multidisciplinary treatment program for severe obesity and preoperative bariatric surgery by Fernanda Cristina Carvalho Mattos MAGNO (6380201)

“…It was observed that in the 5th appointment more than 50% of the patients underwent six meals a day. …”

<i>Tg</i>6PGDH2 and <i>Tg</i>RPI are required to incorporate glucose-derived carbon into the pentose phosphate pathway. by Ningbo Xia (13584299)

Proposed models for PPP metabolism under various conditions. by Ningbo Xia (13584299)

Data_sheet_1_Therapeutic effect of psilocybin in addiction: A systematic review.docx by Pim B. van der Meer (9606147)

“…In a pilot study (n = 10), the percentage of heavy drinking days decreased significantly between baseline and weeks 5–12 (mean difference of 26.0, 95% CI = 8.7–43.2, p = 0.008). …”

Targeted Quantitative Proteomics Revealed Arsenite-induced Proteasomal Degradation of RhoB in Fibroblast Cells by Lok Ming Tam (4419121)

“…In addition, small GTPase signaling is known to be altered in many types of cancer. By employing a multiple-reaction monitoring (MRM)-based targeted proteomic method, we found that the protein level of RhoB was substantially decreased in IMR90 human lung fibroblast cells upon a 12-h exposure to 5 μM NaAsO₂. …”

Auditory phenotype and immunohistochemical analysis of Fhod3-TG mice. by Ely Cheikh Boussaty (17471493)

“…The survival rate of OHC in TG mice at the basal turn cochlea was significantly decreased compared to the WT control (WT vs TG (%): (IHC)100 vs 100 at apical turn (Api), 98.7± 0.95 vs 97.7±1.51 at middle turn (Mid), 94.7±2.24 vs 85.9±6.90 at basal turn (Base); (OHC) 97.1±1.16 vs 95±2.56 at Api, 96.8±0.36 vs 96.5±1.42 at Mid, 95.6±0.64 vs 75.93±8.98 at base, p* = 0.0233 by two-way ANOVA followed by a Tukey post-hoc test) (WT vs TG in the basal OHC (%): 95.6±0.64 vs 75.93±8.98, <i>p*</i> = 0.023 by Mann-Whitney U test, n = 4). …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”

Table_1_BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists.docx by Andrés Noé (3620534)

“…Samples from 29 children, aged 5-11 years, before and 28 days after a second BNT162b2 vaccination were analysed (V2 + 28). …”

DataSheet_1_BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists.zip by Andrés Noé (3620534)

“…Samples from 29 children, aged 5-11 years, before and 28 days after a second BNT162b2 vaccination were analysed (V2 + 28). …”

The radial water maze latency [s (mean ± SEM)] and number of errors (mean ± SEM) of proton irradiated and control rats on Day 1 and Day 2. by Michael T. Williams (357796)

Exhaled metabolic markers and relevant dysregulated pathways of lung cancer: a pilot study by Yingchang Zou (12217753)

Evolution over time of Pao/Fioratio following PV measurements and during a control period by Antoine Roch (64984)

“…Data are expressed as percentage increase or decrease in Pao/Fioratio at 5, 15, 30 and 60 minutes as compared with values before PV measurement or the control period. …”